Live tape
Top 8, mentions 7d28,335NVDA17,030 mentions▲ +0.03MSFT1,928 mentions-0.02AMD1,908 mentions▲ +0.10GOOGL1,892 mentions▲ +0.04AAPL1,539 mentions▲ +0.05SPCX1,482 mentions▲ +0.07SPY1,358 mentions▲ +0.05NBIS1,198 mentions▲ +0.07

Equity · Healthcare

PACB

NASDAQ

Pacific Biosciences of California (PACB)

1.96 USD −0.76% vs prior close Nov 13, 2026
Pacific Biosciences of California, Inc. price graph
42 sessions
3.0 1.0 17 Sep 13 Nov

The line runs 1.38 USD on 17 September through 1.96 USD on 13 November, on a scale from 1.0 to 3.0. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
611.8M USD
Revenue, year to Dec 2025
160.0M USD
EPS, diluted, year to Dec 2025
−1.82 USD
52-week range
1.15 USD – 2.91 USD
Avg volume
1.1M
Mentions, 30 days
1

as of Nov 13, 2026

Have Pacific Biosciences of California (PACB) insiders bought or sold shares recently?

In the 90 days to 15 Nov 2026, Pacific Biosciences of California insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 17 Feb 2026, show no open-market purchase.

Form 4, 90 days to 15 Nov 2026, newest reported trade 6 Oct 2026

0buys
2sells
$2.09Mnet sold
1other filings
Have Pacific Biosciences of California (PACB) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
06 Oct 2026Gibson James R IISee RemarksSell661,8152.1M USD
17 Aug 2026Van Oene MarkSee RemarksSell26,91130K USD
Sold2 open-market sales688,726$2.09M
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
Have Pacific Biosciences of California (PACB) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
06 Oct 2026Gibson James R IISee RemarksOption exercise500,000590K USD

Which funds hold Pacific Biosciences of California (PACB)?

2 of the 45 institutional funds we track reported a Pacific Biosciences of California position for the quarter ended 30 Sep 2026 — a combined 71.5M USD; the latest of those filings landed 13 Nov 2026.

Form 13F

Which funds hold Pacific Biosciences of California (PACB)?
FundPositionSharesValueShares q/q
ARK Investment ManagementHeld (±25%)29,749,89370.5M USD−0.1%
Marshall WaceAdded417,726990K USD+155.3%
Renaissance TechnologiesExited

What has been filed or recorded for Pacific Biosciences of California (PACB)?

The filings we hold for Pacific Biosciences of California, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Pacific Biosciences of California (PACB)?
And
14 Oct 2026Fails to deliverShares failed to deliver30,022 shares62K USD notional · 0.010% of shares out
13 Oct 2026Fails to deliverShares failed to deliver1,000 shares2K USD notional · <0.001% of shares out
09 Oct 2026Fails to deliverShares failed to deliver4,423 shares10K USD notional · 0.001% of shares out
08 Oct 2026Fails to deliverShares failed to deliver1,645 shares4K USD notional · 0.001% of shares out
07 Oct 2026Fails to deliverShares failed to deliver423 shares1K USD notional · <0.001% of shares out
06 Oct 2026Fails to deliverShares failed to deliver4,991 shares14K USD notional · 0.002% of shares out
30 Sep 2026Fails to deliverShares failed to deliver71,614 shares131K USD notional · 0.023% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.12 USD
30 Sep 2026FinancialsTotal assets721.1M USDat period end
30 Sep 2026FinancialsTotal equity−61.4M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.14 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.03 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −1.82 USD
31 Dec 2025FinancialsRevenue160.0M USDfiscal year
31 Dec 2025FinancialsNet income−546.4M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−1.82 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.13 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.14 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −1.44 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −1.59 USD

What is Reddit saying about Pacific Biosciences of California (PACB)?

Reddit mentioned PACB 1 times in the 30 days to 14 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 14 November 2026.

30-day window, Method

1mentions, 30 days
1communities

How do Reddit mentions of Pacific Biosciences of California (PACB) compare with its price?

Share ↗
Post on X Share on Reddit Share on LinkedIn
1 mentions

Which subreddits are talking about Pacific Biosciences of California (PACB)?

30 days

Which subreddits are talking about Pacific Biosciences of California (PACB)?
CommunityShareMentionsNet sentiment
r/wallstreetbets100%1+0.11

What do people ask about Pacific Biosciences of California (PACB)?

From live data
What did Pacific Biosciences of California shares close at?1.96

Pacific Biosciences of California closed at 1.96 USD on 13 Nov 2026, down 0.76% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Pacific Biosciences of California’s market cap?611.8M

Pacific Biosciences of California is worth 611.8M USD by market value as of 13 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is Pacific Biosciences of California’s revenue?160.0M

Pacific Biosciences of California reported revenue of 160.0M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Pacific Biosciences of California insiders bought or sold shares recently?2 sales

In the 90 days to 15 Nov 2026, Pacific Biosciences of California insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 17 Feb 2026, show no open-market purchase. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders

Which funds own Pacific Biosciences of California?2 of 45

2 of the 45 funds we track reported a Pacific Biosciences of California position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were ARK Investment Management, Marshall Wace and Renaissance Technologies. See Funds

When did Pacific Biosciences of California last report earnings?−0.12

Pacific Biosciences of California last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.12 USD; no next date is announced in SEC filings yet. See Filings

What is Reddit saying about Pacific Biosciences of California?0 mentions

Pacific Biosciences of California was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings